Recruiting
Phase 2

IVC with Gemcitabine-Carboplatin

Sponsor:

University of Kansas Medical Center

Code:

NCT06493370

Conditions

Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intravenous ascorbic acid/vitamin C

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-03. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2025-02-20.